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In previous work  (1) fluorescein-labeled, aggregated human  ~/-globulin was 
demonstrated to be a  sensitive reactant for the detection of rheumatoid factor 
in  frozen  sections  of  synovial  membranes  and  lymph  nodes  obtained  from 
patients with  active rheumatoid  arthritis.  Observations of similar kind have 
been  made  with  fluorescent  antigen-rabbit antibody  (immune)  complex  and 
are reported here. Thus in analogy with the precipitin test and the sheep cell 
agglutination reaction for rheumatoid factor  (2), two categories of fluorescent 
reactants have been prepared for the detection of rheumatoid factor in tissue 
sections. 
Materials and Methods 
Fluorescent Immune Complex and Other Fluors.--The starting material for the preparation 
of the fluorescent complex was rabbit antiserum against bovine serum albumin.  The rabbits 
were immunized  by intramuscular injections of crystalline bovine serum albumin (Armour 
Laboratories) incorporated in complete Freund adjuvant (Difco Laboratories). Each of six 
New Zealand brown rabbits received  an initial injection of 10 rag. bovine serum albumin, 
followed by a  similar injection 1 week  later. Three weeks  after the second injection test 
bleedings were made. All samples of serum gave a strong precipitin reaction in agar gel with 
bovine serum albumin at a concentration of 400 ~g. per ml. The rabbits were exsanguinated, 
and the antisera were pooled.  Quantitative precipitin reactions were  then carried out with 
aliquots of the pooled antiserum, and the zone of equivalence was determined with unlabeled 
and fluorescein isothiocyanate-labeled (3) bovine serum albumin.  Immune precipitates were 
formed by the addition of labeled antigen at equivalence,  harvested by centrifugation after 
several days' incubation in the cold, washed several times with chilled saline, and then ren- 
dered in part soluble by the addition of labeled antigen in twice the equivalent amount (4). 
After several days' equilibration in the cold, the soluble complex was obtained in the super- 
natant fluid by centrifugatian. This comprised the fluorescent  immune complex, to be used 
as a  staining reactant for rheumatoid factor. An immune complex was similarly prepared 
with unlabeled antigen for control staining procedures.  As shown by the Ouchterlony  tech- 
nique, both the labeled and the unlabeled immune complex formed zones of precipitate with 
sera from patients with rheumatoid arthritis. 
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Fluorescein-labeled aggregated human ~-globulin and fluorescent antibody for 19S human 
T-globulin were prepared as previously described (1) and were tested for their specificity. 
Source and Na2ure of Tissues.--Tissues were obtained from 7 patients: 5 adults, 4 females 
and 1 male, ranging in age from 31 to 69 years, with classical active rheumatoid arthritis, of 
7 to  13 years' duration,  1+  to 4+  latex fixation tests, and systemic treatment with corti- 
costeroids for several years; and  2 children, a  boy, age 8,  and  a  girl, age 9, with juvenile 
rheumatoid arthritis of ~  and 5 years' duration respectively, -  and 4- latex fixation tests, and 
no systemic treatment with corticosteroids. Diagnostic biopsies and surgical procedures per- 
formed on these patients by the hospital staff provided the following specimens for study: 
synovial and capsular tissues of knee, 4,  including a preoperative needle biopsy and a total 
synovectomy in an adult male, a total synovectomy in an adult female, and a synovial biopsy 
in a girl; syaovial tissue of wrist,  1, in an adult female; and lymph nodes, 3, of which two 
were obtained from adult females and one from a  girl. Tissue blocks,  numbering  127, were 
cut from these specimens,  frozen for special  study, and fixed and embedded in paraffin for 
routine study in the following number: synovial tissue, special  52, routine 54;  and  lymph 
nodes, special 9, routine  12. The pathological diagnosis of synovial tissue was in each case 
either  chronic  or  subacute  exudative and  proliferative synovitis histologically compatible 
with rheumatoid arthritis. The lymph nodes were in each instance moderately hyperplastic. 
Control material from 12 patients,  18 to 61 years of age, 6 males and 6 females, without 
rheumatoid arthritis provided the following tissue blocks for study: synovial tissue, special 34, 
routine 42; and lymph nodes, special 5, routine 4. Among the synovial tissues were surgical 
specimens obtained from patients with degenerative and traumatic osteoarthritis, infectious, 
tuberculous, and gouty arthritis, pigmented villonodular synovitis, synovlal chondromatosis, 
Reiter's syndrome,  and  Boeck's sarcoid. The lymph nodes were derived from two sources: 
biopsies of hyperplastic and normal nodes, and autopsies in an example each of Waldenstr6m's 
macroglobulinemla (5) and Boeck's sarcoid. 
In the present study approximately 400 frozen sections, treated with fluors, were examined 
and described and 500 individual photomicrographs were made as a permanent record of the 
observations. This work comprised a part of a continuing investigation of rheumatoid arthritis 
in which to date  more than  1200 immunofluorescence reactions  have been carried  out on 
tissue sections. 
Preparation of Tissue Se~gons.--Frozen sections of unfixed tissues were cut in a microtome 
cryostat at an indicated thickness of 4 # as previously described (i). On rare occasion, fresh 
tissue blocks with a volume of about 1 mm.  s were frozen at the temperature of liquid nitrogen, 
dried in the frozen state, embedded with diethylene glycol distearate (6), and sectioned with a 
glass knife at 1 to 2 # with a Servall Porter-Blum microtome. 
Fluorescence Staining  Proceclures.--The general  steps  in  the  procedures,  including  the 
absorption of fluors with rabbit bone marrow powder, were carried out as described elsewhere 
(1).  Fluorescent immune complex and,  for correlative work, fluorescent aggregated human 
v-globulin (1),  were used,  with the appropriate  control procedures  noted  below,  to detect 
rheumatoid factor; and fluorescein-labeled rabbit antibody of known immunospecificity (1) 
was used to detect 19S human 7-globulin. Staining  reactions were carried out for 1 hour at 
room temperature. 
Control Procedures.--The specificity of the apple-green staining patterns in tissue sections 
treated  with  fluorescent  immune  complex and  attributed  to  the  presence  of  rheumatoid 
factor was confirmed by inhibition of the reactions with (a) unlabeled rabbit antibody against 
19S human v-globulin, (b) unlabeled immune complex, and  (c) unlabeled aggregated human 
~,-globulin. In these inhibition reactions the sections were exposed to the appropriate  protein 
solution for 2 hours at room temperature, followed by washing in buffered saline and staining 
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reactions was shown by the treatment of tissue sections  with heat (56°C. for ~  hour) and by 
the use of fluorescent immune complex prepared from complement-inactivated  rabbit anti- 
serum against bovine serum albumin, neither of which altered the results. 
The specificity of  the staining patterns  obtained with  fluorescent aggregated human 
3,-giobulin and attributed to the presence of rheumatoid factor was confirmed,  as before (1), 
by inhibition with either (a) unlabeled rabbit antibody against 19S human ,c-globulin or (b) 
unlabeled aggregated human ,c-globulin. Prior treatment of sections with unlabeled immune 
complex  inhibited, variously, none or some of the staining reaction with fluorescent  aggregated 
human "r-globulin,  depending  upon individual attributes of the pathological  material studied. 
As in previous work (1), the staining reaction for 19S human -c-giobulin  was specifically 
inhibited with unlabeled rabbit antibody against 19S human ~-giobulin. 
Oth~ Mahods.--Fluorescence microscopy and  photography  (7)  and  correlative histo- 
pathologic studies (1) of the customary variety were carried out, as described in previous 
publications. 
RESULTS 
Synovial  Membranes  in  Rheumatoid  Arthritis.--The  cells  which  contain 
rheumatoid factor detectable with fluorescent immune complex comprise but a 
minute  portion of the  cell-rich inflammatory exudate that  lies beneath  the 
surface mesothelium of the thickened synovial membrane and in the stalks of 
the hypertrophic synovial villi. The cells with rheumatoid factor are plasma 
cells in various stages of development and include immature (Fig.  1), mature 
(Figs. 2 and 3), and Russell body types (Fig. 5). 
While of similar appearance (Fig. 7), plasma cells which contain rheumatoid 
factor  detectable  with  fluorescent  aggregated  human  -/-globulin  are  more 
numerous (Fig.  9)  than those which react with fluorescent immune complex. 
The lack of correspondence in the number of plasma cells which stain with the 
two reactants for rheumatoid factor is also shown by one of the blocking pro- 
cedures. Mter exposure to unlabeled immune complex, the subsequent staining 
reaction with fluorescent aggregated human "g-globulin persists in a substantial 
population of plasma  cells  (Figs.  12 and  13).  However prior treatment with 
unlabeled  aggregated  human  "g-globulin  completely inhibits  the  staining  re- 
action with fluorescent immune complex. 
Plasma  cells  containing  rheumatoid  factor have  been  demonstrated  with 
fluorescent aggregated human ~.-globulin,  and in lesser number with fluorescent 
immune  complex,  in  each  example  of  active  rheumatoid  synovitis  studied, 
whether occurring in adults  (Figs.  1 to 3, 5,  7,  and 9) or children,  (Fig.  11), 
and in the presence or the absence of positive latex fixation tests. On one oc- 
casion, a needle biopsy provided sufficient synovial tissue for the detection of 
cellular rheumatoid factor. 
Plasma cells which contain macroglobulin (19S human "g-globulin) detectable 
with fluorescent antibody are present in greater number than those containing 
rheumatoid factor, although the cellular type (Figs.  14,  15, and 19)  and dis- 
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exclusively formed  and  contained in  the cytoplasm,  these  proteins  are also 
demonstrable in the nucleus of an occasional plasma cell (Fig. 22). 
Lymph Nodes  in Rheumatoid  Arthritis.--Two  categories of cells  in lymph 
nodes contain rheumatoid factor detectable with fluorescent immune complex: 
(a) germinal center cells,  (Fig. 6)  and plasma cells of immature, mature, and 
Russell body types (Fig. 4). While similar in appearance, these cellular sites of 
rheumatoid factor are less numerous than those demonstrated with fluorescent 
aggregated  human  ~,-globulin  (Figs.  8  and  10),  and  comprise  but  a  small 
portion of the plasma cells  and  the  germinal centers which contain macro- 
globulin (Figs. 17 and 18). In active rheumatoid arthritis, lymph nodes some- 
times become hyperplasfic, and in that event germinal cells containing macro- 
globulin may be  so numerous that  two or  three  immunofluorescent centers 
are seen in the same low-power field (Fig. 18), and as many as 50 or more may 
be counted in a single section (with an area of about 1 cm3). When a companion 
section of the  same  block is stained with fuorescent aggregated human  ~/- 
globulin, only three or four immunofluorescent centers, or at most five or six, 
may occur in the entire section, and in the reaction with fluorescent immune 
complex only one or two, or perhaps none, may be seen. The number of immuno- 
fluorescent plasma cells,  principally internodular in distribution, also display 
progressively decreasing  frequencies  when lymph node  sections  are  stained 
with fluorescent antibody for macroglobulin,  with fluorescent aggregate, and 
with fluorescent complex. 
Control  Tissues.--Normal  and pathological synovial and  capsular  tissues, 
lymph nodes, and connective tissues obtained from individuals without rheuma- 
toid arthritis are not stained with the fluorescent immune complex. The synovial 
tissues  include those obtained in various forms of arthritis  (traumatic,  de- 
generative,  tuberculous,  infectious,  and  gouty  arthritis),  pigmented  villo- 
nodular synovitis, synovial chondromatosis, Reiter's syndrome, and Boeck's 
sarcoid. The lymph nodes include those of normal and hyperplastic appear- 
ance, as well as pathological lymph nodes in an example each of Boeck's sarcoid 
and WaldenstrSm's macroglobulinemia. This control material,  with a  single 
exception, is likewise not stained with fluorescent aggregated human ~,-globulin. 
In an unusual example of Waldenstriim's macroglobulinemia (5) approximately 
50 per cent of the mononuclear cells  (principally immature plasma cells)  in a 
lymph node are stained with fluorescent aggregated human ~,-globulin (Fig. 16) 
and with fluorescent antibody for macroglobulin (Figs.  20 and 21),  but not 
with fluorescent immune complex. A  notable serological feature of  this case, 
which is discussed fully elsewhere (5), was the presence of very strong precipitin 
reactivity with aggregated human -r-globulin,  with an unusual pH optimum, 
and a negative sheep cell agglutination test. 
Macroglobulin detectable with fluorescent antibody (but not with fluorescent 
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center cells of normal lymph nodes and exeptionally in plasma cells of synovial 
inflammatory exudates in conditions unrelated to rheumatoid arthritis. 
DISCUSSION 
As shown by a variety of serological  tests  (2),  the serum of a  majority of 
patients with rheumatoid  arthritis,  and a  minority of individuals with other 
diseases, contains an unusual category of macroglobulins (8-10), called rheuma- 
toid factor.  This  factor has  the  capacity to  agglutinate  particulate  bodies, 
such as erythrocytes and latex particles, which have been coated with a sensi- 
tizing  globulin,  or reactant. Two principal categories of reactants are used in 
the serological  tests for rheumatoid factor: rabbit immune (antibody-antigen) 
complex in the extensively studied sheep cell agglutination test (11) and altered 
human v-globulin, or aggregated human v-globulin  (12),  as in the precipitin 
test  (13).  In  this  and  the  previous  study  (1),  two  analogous  categories  of 
fluorescent reactants  (fluorescent  immune complex and fluorescent aggregate) 
were prepared, and rheumatoid factor was detected in silu in sections of tissues. 
The synovial membranes and the lymph nodes of adults and children  with 
rheumatoid arthritis and with positive, equivocal, and negative latex fixation 
tests contained rheumatoid factor. The cellular sites of origin  of rheumatoid 
factor were found to be similar in kind (plasma cells and germinal  center cells) 
when detected with the two categories of fluorescent reactants, but the number 
of cells stained with fluorescent aggregate was substantially greater than that 
stained  with  fluorescent immune  complex.  Prior  treatment  of sections with 
unlabeled  aggregated  human  v-globulin  inhibited  subsequent  staining  re- 
actions  with  fluorescent  aggregate  and  with  fluorescent  immune  complex; 
whereas prior treatment with unlabeled immune complex diminished,  but did 
not  abolish,  the  staining  reaction  with fluorescent  aggregate.  These  experi- 
mental  findings  are  consistent  with  the  behavior  anticipated  for  cellular 
rheumatoid factor, were it primarily an antibody directed to an altered human 
v-globulin and cross-reacting  with rabbit v-globulin, a possible interpretation 
that  has been proffered from a  consideration  of the quantitative  serological 
data obtained with the two reactants (14). However, an alternative explanation 
is possible; namely, that  there are several (two or more) cellular  rheumatoid 
factors directed against different antigenic components of aggregated human 
v-g|obulln and that  some of these components are present also in rabbit im- 
mune  complex.  In  support  of this  possibility it  has been shown that  many 
sera from patients  with rheumatoid  arthritis  produce two distinct precipitin 
lines  with  aggregated human  v-globulin  when tested by gel  diffusion  (15). 
Moreover rheumatoid  factor has been fractionated into  distinct  components 
capable of reacting with either rabbit antibody  or altered  human v-globulin 
(16).  Consequently it is possible that  cellular  rheumatoid factor of one type 
(and origin)  reacts with  a  component present only in aggregated human  V- 480  PATIIOGENESIS OF RHEUMATOID  ARTHRITIS 
globulin and  that  cellular rheumatoid factor of another  type reacts  with a 
component common to both the aggregated human "r-globulin  and the rabbit 
immune complex. Further studies will be required for proof or denial of one or 
another of these explanations. 
What are the pathogenic implications of these observations dealing with the 
cellular origin of rheumatoid factor? The studies show that cells  which form 
the factor are an integral part of the synovial inflammatory exudate in rheuma- 
toid arthritis  and occur also in remote sites as well; namely, in  the lymph 
nodes. The cells which form rheumatoid factor belong to the same families of 
cells  which produce  antibodies  (17),  7S  ~,-globulin  (18),  and  macroglobulin 
(1,  19, 5).  Thus the cellular origin, as well as the chemical and the immuno- 
logical attributes, of rheumatoid factor suggests an antibody-like nature and 
function. In that event a  search should be undertaken in the tissues for the 
provocative antigen, such as an altered human ~,-globulin  (20), and for lesion- 
associated protein  precipitates  having  the  composition and attributes antic- 
ipated  for a  rheumatoid factor-antigen complex  (21).  This  latter  we  have 
demonstrated recently in the kidney and spleen of a  patient who died with 
amyloidosis secondary to rheumatoid arthritis. Macroglobulin, in part showing 
the reactivity of rheumatoid factor, and 7S  ~'-globulin  were localized in the 
amyloid lesions,  Figs. 23 and 24. 
On  the other hand, in rheumatoid arthritis as in certain other conditions 
plasma cells may proliferate and produce unusual proteins which do not have 
antibody function. The plasma cells and the abnormal serum proteins which 
occur  in  multiple  myeloma  and  in  WaldenstrSm's  macroglobulinemia  are 
illustrative examples. None the less,  a  close relationship of rheumatoid factor 
to  a  pathogenic mechanism in rheumatoid arthritis  seems  evident from the 
characteristic presence in the actively inflamed synovial membrane of plasma 
cells forming and liberating rheumatoid factor. 
SUMMARY  AND  CONCLUSIONS 
In analogy with the two categories of reactants which are used in the sero- 
logical  tests  for  the  unusual  category of  macroglobulins called  rheumatoid 
factor,  two  fluorescent  reactants  have  been  prepared  for  the  detection  of 
rheumatoid factor in situ in tissue sections: fluorescent antigen-rabbit antibody 
(immune)  complex, in the present study, and fluorescent aggregated human 
-},-globulin, in  previous  work. 
Plasma cells in the synovial membrane and germinal center cells and inter- 
nodular plasma  cells  in  lymph nodes  are  the  sites  of  origin  of rheumatoid 
factor in active rheumatoid arthritis, whether occurring in adults or children. 
Plasma cells and germinal center cells which form rheumatoid factor detectable 
with fluorescent immune complex are less numerous than those which contain MELLORS, NOWOSLAWSKI, KORN'GOLD, AND  SENGSON  481 
factor demonstrable with fluorescent  aggregate.  In the  same tissues,  plasma 
cells  and  germinal  center  cells  which  contain  macroglobulin  (19S  human 
"r-globulin)  detectable  with  fluorescent  antibody--but  not  showing  the  re- 
activity  of  rheumatoid  factor--are  more  abundant  than  those  containing 
rheumatoid factor. 
While  macroglobulin and rheumatoid factor are almost exclusively formed 
in the  cytoplasm, these proteins  are also detectable in the nucleus of an oc- 
casional plasma cell. 
Normal and pathological synovial and  capsular  tissues,  lymph nodes,  and 
connective tissues obtained from individuals without rheumatoid arthritis are 
not stained with fluorescent immune complex or, except for an unusual example 
of WaldenstrSm's macroglobulinemia, with fluorescent aggregate. 
The cellular origin, as well as certain chemical and immunological attributes, 
of  rheumatoid  factor  suggests  an  antibody-like  nature  and  function.  The 
observations  cited  are  consistent  with  the  behavior  anticipated  for  ceUular 
rheumatoid factor, were it primarily an antibody direct to an altered hmnan 
v-globulin and cross-reacting with rabbit v-globulin. However, it is also possible 
that there are two or more cellular rheumatoid factors. 
Lesion-associated protein  precipitates  having  the  composition  anticipated 
for rheumatoid factor-antigen complex are localized in the amyloid depositions 
in kidney and spleen of an individual who died with amyloidosis secondary to 
rheumatoid arthritis. 
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Addendum.--Since this paper was submitted, we have succeeded in preparing two 
fluorescent  reactants for rheumatoid factor in contrasting colors: fluorescein-labeled 
immune complex (yellow-green)  and rhodamine-labeled aggregated human T-globulin 
(orange-red). When a section of lymph node in active rheumatoid arthritis is stained 
with  these  fluorescent  reactants in  mixture or  in  sequence,  some of the  germinal 
centers are orange-red and  others,  representing a  smaller number,  are  green.  The 
cellular  origin  of two rheumatoid factors has thus been demonstrated. Some of the 
plasma cells in  a  section  of synovial membrane in active rheumatoid arthritis are 
stained orange-red and others, again in smaller number,  are  green.  A  few plasma 
cells appear to have combinations of orange-red and green colors,  but  this is stated 
only as a preliminary observation which requires further study. 
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EXPLANATION OF PLATES 
These  are  fluorescence  photomicrographs  of  frozen  sections,  and  descriptions 
pertain to the immunospecific fluorescence  imparted by fluorescein-labeled  reactants 
and antibodies. 
PLATE 49 
FIG.  1.  Synovial membrane  in  rheumatoid  arthritis.  An  immature  plasma  cell 
with  eccentric nucleus  devoid  of  staining  and  homogeneous cytoplasm  containing 
rheumatoid factor  (white  areas).  Stained  with  fluorescent rabbit  immune complex. 
X  1500. 
FIG.  2.  Synovial membrane  in  rheumatoid  arthritis.  Two  mature  plasma  cells 
containing rheumatoid factor in the cytoplasm. Fluorescent immune complex. X  1500. 
FIo.  3.  Synovial membrane  membrane  in  rheumatoid  arthritis.  Mature  plasma 
cell containing cytoplasmic rheumatoid factor with clumped and fibrillated  distribu- 
tion. Fluorescent immune complex.  X  1500. 
FIG. 4. Lymph node in rheumatoid arthritis.  Russell body plasma cell containing 
rheumatoid factor in the cytoplasmic spherical bodies. Fluorescent immune complex. 
X  1500. 
FIG. 5.  Synovial membrane in  rheumatoid arthritis.  On the top, a  Russell  body 
plasma  cell  with bizarre appearance  brought about by the  confluence  of the  cyto- 
plasmic bodies and loss of contents. Rheumatoid factor persists in outer membranes. 
On  the bottom,  tissue  deposition  of rheumatoid  factor derived  from cell  residues. 
Fluorescent immune complex.  X  1500. 
FIG.  6.  Lymph  node  in  rheumatoid  arthritis.  Rheumatoid  factor  in  germinal 
center cells  occupying the  outer half of the germinal center.  More  commonly, the 
central portion of the nodule is richest in content of rheumatoid factor, as shown in 
Fig. 10.'Fluorescent immune complex.  X  170. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 113  PLATE  49 
(MeUors et  al.:  Pathogenesis of rheumatoid arthritis) PLATE 50 
FIG.  7.  Synovial membrane  in  rheumatoid  arthritis.  Three  mature  plasma  cells 
with  cytoplasmic  rheumatoid  factor.  Fluorescent  aggregated  human  3'-globulin. 
X  1500. 
Fro. 8.  Lymph node  in  rheumatoid arthritis. Russell body plasma cell containing 
rheumatoid factor in the cytoplasmic spherical bodies. Compare with Fig. 4.  Fluores- 
cent aggregate.  X  2000. 
F~c,. 9.  Synovial membrane  in rheumatoid arthritis. Rheumatoid factor in plasma 
cells of immature, mature, and Russell body types (identified at higher magnification), 
as well as in so called "prismatic" forms. Fluorescent aggregate.  X  400. 
FIG. 10. Lymph node in rheumatoid arthritis. Rheumatoid factor in the cytoplasm 
and cytoplasmic continua of germinal center cells (so  called "large pale" cells). The 
surrounding mantle of mature lymphocytes (not shown)  is always dew~id of rheuma 
told factor. See also Fig. 17. Fluorescent aggregate. ×  51(/. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  113  PLATE  50 
(Mellors el  al. : Pathogenesis of rheumatoid arthritis) PLATE  5 1 
FIG.  11.  Synovial membrane  in juvenile rheumatoid arthritis. A cluster of four or 
five mature pl/tsma cells containing rheumatoid factor. Fluorescent aggregate. X  1500. 
Fie,.  12.  Synovial membrane in rheumatoid arthritis. Field of plasma cells, similar 
to  those in  Fig. 9,  containing rheumatoid factor. The section was first treated  with 
unlabeled immune complex and then stained with fluorescent aggregate.  X  400. 
FlO.  13.  Synovial membrane in rheumatoid arthritis. Plasma cell containing rheu 
matoid factor. Unlabeled immune complex followed by fluorescent aggregate.  X  1500. 
Fit;. 14. Synovial membrane in juvenile rheumatoid arthritis. Plasma cell containing 
macroglobulin (19S  T-globulin) in the cytoplasm. See also Fig.  11.  Fluorescent anti- 
t)ody stain.  X  1500. 
Fro.  15.  Lymph  node  in  juvenile rheumatoid  arthritis.  Russell  body plasma cell 
containing macroglobulin  in  the  cytoplasmic spherical bodies.  Some  of  the  plasma 
cells in  this  tissue were  also shown  to  contain rheumatoid  factor.  Fluorescent anti- 
body.  X  1500. 
Fro. 16. Lymph node in Waldenstr6m's macroglo/mlinemia, hnmature plasma cells 
and plasmablasts containing macroglobulin with the reactivity of rheumatokl factor. 
See also Figs. 20 and 21. Fluorescent aggregate. ×  163. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  113  PLATE  51 
(Mellors et al.:  Pathogenesis of rheumatoid  arthritis) PLATE 52 
FIG. 17. Lymph node in rheumatoid arthritis. Three germinal centers and scattered 
internodular plasm& cells (identified at higher magnification) containing macroglobu- 
lin. Fluorescent antibody.  X  136. 
F~G. 18.  Lymph node  in rheumatoid arthritis. Germinal center containing macro- 
globulin. Fluorescent antibody. ×  850. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  113  PLATE  52 
(Mellors et  a/.:  Pathogenesis of rheumatoid  arthritis) PLATE 53 
FIG. 19. Lymph node in juvenile rheumatoid arthritis. Germinal center containin~ 
macroglobulin. Fluorescent antibody. X 200. 
F~G. 20.  Lymph  node  in  Waldenstr~m's macroglobulinemia, immature plasma 
cells and plasmablasts containing macroglobulin. Fluorescent antibody. X  400. 
FIG. 21.  Lymph node  in Waldenstr6m's macroglobulinemia. Similar to  Fi~.  20. 
×  1000. 
F~G. 22. Synovial membrane in rheumatoid arthritis. Mature plasma cell containing 
macroglobulin in cytoplasm and in a small central focus  in the nucleus. Rheumatoid 
factor has also been detected in the nucleus on rare occasion.  Fluorescenl antihody. 
X  2000. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 113  PLATE  53 
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FIG.  23.  Kidney  in  amyloidosis secondary  to  rheumatoid  arthritis.  Rheumatoid 
factor  in  glomerular capillary tuft  in  locations corresponding  to  amyloid deposits. 
Macroglobulin lacking the  reactivity of  rheumatoid  factor  and  7S  ",/-globulin  were 
also detectable in these sites. Fluorescent aggregate.  X 400. 
FIG.  24.  Spleen  in  amyloidosis secondary  to  rheumatoid  arthritis.  Rheumatoid 
factor in thickened walls of small blood vessels, in locations corresponding to amyloid 
deposits. Macroglobulin lacking the reactivity of rheumatoid factor and 7S 3,-globulin 
were also detectable in these sites. Fluorescent aggregate.  ×  510. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  113  PLATE  54 
(Mellors  et al.:  Pathogenesis of rheumatoid  arthritis) 